• 1
    Roth DA, Longaker MT, McCarthy JG, Rosen DM, McMullen HF, Levine JP, Gold LI 1997 Studies in cranial suture biology: Part I. Increased immunoreactivity for transforming growth factor-beta (β1, β2, β3) during rat cranial suture fusion. J Bone Miner Res 12:311321.
  • 2
    Roth DA, Bradley JP, Levine JP, McMullen HF, McCarthy JG, Longaker MT 1996 Studies in cranial suture biology: Part II. Role of the dura in cranial suture fusion. Plast Reconstr Surg 97:693699.
  • 3
    Levine JP, Bradley JP, Roth DA, McCarthy JG, Longaker MT 1998 Studies in cranial suture biology: Regional dura mater determines overlying suture biology. Plast Reconstr Surg 101:14411447.
  • 4
    Bradley JP, Levine JP, Blewett C, Krummel T, McCarthy JG, Longaker MT 1996 Studies in cranial suture biology: In vitro cranial suture fusion. Cleft Palate Craniofac J 33:150156.
  • 5
    Bradley JP, Levine JP, Roth DA, McCarthy JG, Longaker MT 1996 Studies in cranial suture biology: IV. Temporal sequence of posterior frontal cranial suture fusion in the mouse. Plast Reconstr Surg 98:10391045.
  • 6
    Bradley JP, Levine JP, McCarthy JG, Longaker MT 1997 Studies in cranial suture biology: Regional dura mater determines in vitro cranial suture fusion. Plast Reconstr Surg 100:10911102.
  • 7
    Mehrara BJ, Mackool RJ, McCarthy JG, Gittes GK, Longaker MT 1998 Immunolocalization of basic fibroblast growth factor and fibroblast growth factor receptor-1 and receptor-2 in rat cranial sutures. Plast Reconstr Surg 102:18051820.
  • 8
    Mehrara B, Steinbrech D, Saadeh P, Gittes G, Longaker M 1999 Expression of high-affinity receptors for TGF-beta during rat cranial suture fusion. Ann Plast Surg 42:502508.
  • 9
    Mehrara B, Greenwald J, Chin G, Dudziak M, Sagrioglu J, Steinbrech D, Saadeh P, Gittes G, Longaker M 1999 Regional differentiation of rat cranial suture-derived dural cells is dependent on association with fusing and patent cranial sutures. Plast Reconstr Surg 104:10031013.
  • 10
    Opperman LA, Sweeney TM, Redmon J, Persing JA, Ogle RC 1993 Tissue interactions with underlying dura mater inhibit osseous obliteration of developing cranial sutures. Dev Dyn 198:312322.
  • 11
    Opperman LA, Passarelli RW, Morgan EP, Reintjes M, Ogle RC 1995 Cranial sutures require tissue interactions with dura mater to resist osseous obliteration in vitro. J Bone Miner Res 10:19781987.
  • 12
    Opperman LA, Chhabra A, Nolen AA, Bao Y, Ogle RC 1998 Dura mater maintains rat cranial sutures in vitro by regulating suture cell proliferation and collagen production. J Craniofac Genet Dev Biol 18:150158.
  • 13
    Steinbrech DS, Mehrara BJ, Saadeh PB, Chin G, Dudziak ME, Gerrets RP, Gittes GK, Longaker MT 1999 Hypoxia regulates VEGF expression and cellular proliferation by osteoblasts in vitro. Plast Reconstr Surg 104:738747.
  • 14
    Weir EC, Horowitz MC, Baron R, Centrella M, Kacinski BM, Insogna KL 1993 Macrophage colony-stimulating factor release and receptor expression in bone cells. J Bone Miner Res 8:15071518.
  • 15
    Saadeh PB, Mehrara BJ, Steinbrech DS, Dudziak ME, Greenwald JA, Luchs JS, Spector JA, Ueno H, Gittes GK, Longaker MT 1999 Transforming growth factor-beta1 modulates the expression of vascular endothelial growth factor by osteoblasts. Am J Physiol 277:C628C637.
  • 16
    Rowe NM, Mehrara BJ, Dudziak ME, Steinbrech DS, Mackool RJ, Gittes GK, McCarthy JG, Longaker MT 1998 Rat mandibular distraction osteogenesis: Part I. Histologic and radiographic analysis. Plast Reconstr Surg 102:20222032.
  • 17
    Mehrara BJ, Rowe NM, Steinbrech DS, Dudziak ME, Saadeh PB, McCarthy JG, Gittes GK, Longaker MT 1999 Rat mandibular distraction osteogenesis: II. Molecular analysis of transforming growth factor beta-1 and osteocalcin gene expression. Plast Reconstr Surg 103:536547.
  • 18
    Harada H, Tagashira S, Fujiwara M, Ogawa S, Katsumata T, Yamaguchi A, Komori T, Nakatsuka M 1999 Cbfa1 isoforms exert functional differences in osteoblast differentiation. J Biol Chem 274:69726978.
  • 19
    Terao M, Mintz B 1987 Cloning and characterization of a cDNA coding for mouse placental alkaline phosphatase. Proc Natl Acad Sci USA 84:70517055.
  • 20
    Greenwald J, Mehrara B, Spector J, Chin G, Steinbrech D, Saadeh P, Luchs J, Paccione M, Gittes G, Longaker M 1999 Biomolecular mechanisms of calvarial bone induction: Immature vs. mature dura mater. Plast Reconstr Surg 105:13821392.
  • 21
    Liu YH, Tang Z, Kundu RK, Wu L, Luo W, Zhu D, Sangiorgi F, Snead ML, Maxson RE 1999 Msx2 gene dosage influences the number of proliferative osteogenic cells in growth centers of the developing murine skull: A possible mechanism for MSX2-mediated craniosynostosis in humans. Dev Biol 205:260274.
  • 22
    Kueng W, Silber E, Eppenberger U 1989 Quantification of cells cultured on 96-well plates. Anal Biochem 182:1619.
  • 23
    Bravo R, Macdonald-Bravo H 1987 Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: Association with DNA replication sites. J Cell Biol 105:15491554.
  • 24
    Sahni M, Ambrosetti DC, Mansukhani A, Gertner R, Levy D, Basilico C 1999 FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. Genes Dev 13:13611366.
  • 25
    Ormerod MG 1997 Analysis of cell proliferation using the bromodeoxyuridine/Hoechst-ethidium bromide method. Methods Mol Biol 75:357365.
  • 26
    Most D, Levine JP, Chang J, Sung J, McCarthy JG, Schendel SA, Longaker MT 1998 Studies in cranial suture biology: Up-regulation of transforming growth factor-beta1 and basic fibroblast growth factor mRNA correlates with posterior frontal cranial suture fusion in the rat. Plast Reconstr Surg 101:14311440.
  • 27
    Reardon W, Winter RM 1995 The molecular pathology of syndromic craniosynostosis. Mol Med Today 1:432437.
  • 28
    Jabs EW 1998 Toward understanding the pathogenesis of craniosynostosis through clinical and molecular correlates. Clin Genet 53:7986.
  • 29
    Robin NH 1999 Molecular genetic advances in understanding craniosynostosis. Plast Reconstr Surg 103:10601070.
  • 30
    Rutland P, Pulleyn LJ, Reardon W, Baraitser M, Hayward R, Jones B, Malcolm S, Winter RM, Oldridge M, Slaney SF, Poole MD, Wilkie AOM 1995 Identical mutations in FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes. Nat Genet 9:173178.
  • 31
    Lin K, Nolen A, Gampper T, Jane J, Opperman L, Ogle R 1997 Elevated levels of transforming growth factors beta 2 and beta 3 in lambdoid sutures from children with persistent plagiocephaly. Cleft Palate Craniofac J 34:331337.
  • 32
    Yu JC, McClintock JS, Gannon F, Gao XX, Mobasser JP, Sharawy M 1997 Regional differences of dura osteoinduction: Squamous dura induces osteogenesis, sutural dura induces chondrogenesis, and osteogenesis. Plast Reconstr Surg 100:2331.
  • 33
    Mossaz C, Kokich VG 1981 Redevelopment of the calvaria after partial craniectomy in growing rabbits: The effect of altering dural continuity. Acta Anat 109:321331.
  • 34
    Hobar PC, Schreiber JS, McCarthy JG, Thomas PA 1993 The role of the dura in cranial bone regeneration in the immature animal. Plast Reconstr Surg 92:405412.
  • 35
    Roth DA, Gold LI, Han VK, McCarthy JG, Sung JJ, Wisoff JH, Longaker MT 1997 Immunolocalization of transforming growth factor beta 1, beta 2, and beta 3 and insulin-like growth factor I in premature cranial suture fusion. Plast Reconstr Surg 99:300316.
  • 36
    Mehrara B, Fernandez H, Chau D, Sagiroglu J, Steinbrech D, Ueno H, Grau J, Gittes G, Longaker M 1998 Adenovirus-mediated transmission of a dominant negative truncated transforming growth factor beta receptor inhibits in vitro mouse cranial suture fusion. Surg Forum 49:492493.
  • 37
    Opperman LA, Chhabra A, Cho RW, Ogle RC 1999 Cranial suture obliteration is induced by removal of transforming growth factor (TGF)-beta 3 activity and prevented by removal of TGF- beta 2 activity from fetal rat calvaria in vitro. J Craniofac Genet Dev Biol 19:164173.
  • 38
    Centrella M, Massague J, Canalis E 1986 Human platelet-derived transforming growth factor-beta stimulates parameters of bone growth in fetal rat calvariae. Endocrinology 119:23062312.
  • 39
    Centrella M, McCarthy TL, Canalis E 1987 Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. J Biol Chem 262:28692874.
  • 40
    Lundy MW, Hendrix T, Wergedal JE, Baylink DJ 1991 Growth factor-induced proliferation of osteoblasts measured by bromodeoxyuridine immunocytochemistry. Growth Factors 4:257264.
  • 41
    Robey PG, Young MF, Flanders KC, Roche NS, Kondaiah P, Reddi AH, Termine JD, Sporn MB, Roberts AB 1987 Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro. J Cell Biol 105:457463.
  • 42
    Wrana JL, Maeno M, Hawrylyshyn B, Yao KL, Domenicucci C, Sodek J 1988 Differential effects of transforming growth factor-beta on the synthesis of extracellular matrix proteins by normal fetal rat calvarial bone cell populations. J Cell Biol 106:915924.
  • 43
    Sun Y, Zhang W, Lu Y, Hu Y, Ma F, Cheng W 1996 Role of transforming growth factor beta (TGF-beta) in repairing of bone defects. Chin Med Sci J 11:209214.
  • 44
    Moxham JP, Kibblewhite DJ, Dvorak M, Perey B, Tencer AF, Bruce AG, Strong DM 1996 TGF-beta 1 forms functionally normal bone in a segmental sheep tibial diaphyseal defect. J Otolaryngol 25:388392.
  • 45
    Lind M, Schumacker B, Soballe K, Keller J, Melsen F, Bunger C 1993 Transforming growth factor-beta enhances fracture healing in rabbit tibiae. Acta Orthop Scand 64:553556.
  • 46
    Beck LS, Amento EP, Xu Y, Deguzman L, Lee WP, Nguyen T, Gillett NA 1993 TGF-beta 1 induces bone closure of skull defects: Temporal dynamics of bone formation in defects exposed to rhTGF-beta 1. J Bone Miner Res 8:753761.
  • 47
    Robertson SC, Meyer AN, Hart KC, Galvin BD, Webster MK, Donoghue DJ 1998 Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulfide bond in the third immunoglobulin-like domain. Proc Natl Acad Sci USA 95:45674572.
  • 48
    Galvin BD, Hart KC, Meyer AN, Webster MK, Donoghue DJ 1996 Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2/Neu chimeras. Proc Natl Acad Sci USA 93:78947899.
  • 49
    Globus RK, Patterson-Buckendahl P, Gospodarowicz D 1988 Regulation of bovine bone cell proliferation by fibroblast growth factor and transforming growth factor beta. Endocrinology 123:98105.
  • 50
    Mayahara H, Ito T, Nagai H, Miyajima H, Tsukuda R, Taketomi S, Mizoguchi J, Kato K 1993 In vivo stimulation of endosteal bone formation by basic fibroblast growth factor in rats. Growth Factors 9:7380.
  • 51
    Nakamura K, Kawaguchi H, Aoyama I, Hanada K, Hiyama Y, Awa T, Tamura M, Kurokawa T 1997 Stimulation of bone formation by intraosseous application of recombinant basic fibroblast growth factor in normal and ovariectomized rabbits. J Orthop Res 15:307313.
  • 52
    Nakamura K, Kurokawa T, Kawaguchi H, Kato T, Hanada K, Hiyama Y, Aoyama I, Nakamura T, Tamura M, Matsumoto T 1997 Stimulation of endosteal bone formation by local intraosseous application of basic fibroblast growth factor in rats. Rev Rhum Engl Ed 64:101105.
  • 53
    Kimoto T, Hosokawa R, Kubo T, Maeda M, Sano A, Akagawa Y 1998 Continuous administration of basic fibroblast growth factor (FGF-2) accelerates bone induction on rat calvaria—an application of a new drug delivery system. J Dent Res 77:19651969.
  • 54
    Iseki S, Wilkie AO, Heath JK, Ishimaru T, Eto K, Morriss-Kay GM 1997 Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2. Development 124:33753384.
  • 55
    Kim H, Rice D, Kettunen P, Thesleff I 1998 FGF-, BMP- and Shh-mediated signaling pathways in the regulation of cranial suture morphogenesis and calvarial bone development. Development 125:12411251.
  • 56
    Iseki S, Wilkie AO, Morriss-Kay GM 1999 Fgfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault. Development 126:56115620.
  • 57
    Christenson RH 1997 Biochemical markers of bone metabolism: An overview. Clin Biochem 30:573593.
  • 58
    Lawton DM, Andrew JG, Marsh DR, Hoyland JA, Freemont AJ 1997 Mature osteoblasts in human non-union fractures express collagen type III. Mol Pathol 50:194197.
  • 59
    Morike M, Schulz M, Nerlich A, Koschnik M, Teller WM, Vetter U, Brenner RE 1995 Expression of osteoblastic markers in cultured human bone and fracture callus cells. J Mol Med 73:571575.
  • 60
    Lomri A, Lemonnier J, Hott M, de Parseval N, Lajeunie E, Munnich A, Renier D, Marie PJ 1998 Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome. J Clin Invest 101:13101317.
  • 61
    Hirakawa K, Hirota S, Ikeda T, Yamaguchi A, Takemura T, Nagoshi J, Yoshiki S, Suda T, Kitamura Y, Nomura S 1994 Localization of the mRNA for bone matrix proteins during fracture healing as determined by in situ hybridization. J Bone Miner Res 9:15511557.
  • 62
    Power MJ, Fottrell PF 1991 Osteocalcin: Diagnostic methods and clinical applications. Crit Rev Clin Lab Sci 28:287335.
  • 63
    Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg C, Bradley A, Karsenty G 1996 Increased bone formation in osteocalcin-deficient mice. Nature 382:448452.
  • 64
    Gerstenfeld LC, Chipman SD, Glowacki J, Lian JB 1987 Expression of differentiated function by mineralizing cultures of chicken osteoblasts. Dev Biol 122:4960.
  • 65
    Sandberg MM, Aro HT, Vuorio EI 1993 Gene expression during bone repair. Clin Orthop 289:292312.
  • 66
    Collin P, Nefussi JR, Wetterwald A, Nicolas V, Boy-Lefevre ML, Fleisch H, Forest N 1992 Expression of collagen, osteocalcin, and bone alkaline phosphatase in a mineralizing rat osteoblastic cell culture. Calcif Tissue Int 50:175183.
  • 67
    Harris SE, Bonewald LF, Harris MA, Sabatini M, Dallas S, Feng JQ, Ghosh-Choudury N, Wozney J, Mundy GR 1994 Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long tern cultures of fetal rat calvarial osteoblasts. J Bone Miner Res 9:855863.
  • 68
    Felix R, Fleisch H 1976 Pyrophosphatase and ATPase of isolated cartilage matrix vesicles. Calcif Tissue Res 22:17.
  • 69
    Risteli L, Risteli J 1993 Biochemical markers of bone metabolism. Ann Med 25:385393.
  • 70
    Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G 1997 Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89:747754.
  • 71
    Fragale A, Tartaglia M, Bernardini S, Di Stasi AM, Di Rocco C, Velardi F, Teti A, Battaglia PA, Migliaccio S 1999 Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders. Am J Pathol 154:14651477.
  • 72
    Towler DA, Bennett CD, Rodan GA 1994 Activity of the rat osteocalcin basal promoter in osteoblastic cells is dependent upon homeodomain and CP1 binding motifs. Mol Endocrinol 8:614624.
  • 73
    Ducy P, Karsenty G 1998 Genetic control of cell differentiation in the skeleton. Curr Opin Cell Biol 10:614619.